These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37971641)

  • 1. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Raj P; Lei L; Flevaris P; Raj S; Sheldon R
    Clin Auton Res; 2023 Dec; 33(6):811-819. PubMed ID: 37971641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Heart Rhythm; 2020 Jul; 17(7):1151-1158. PubMed ID: 32151742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasovagal syncope: asystole provoked by head-up tilt testing under sertraline therapy.
    Lenk MK; Alehan D; Ozme S; Celiker A; Ozer S
    Turk J Pediatr; 1997; 39(4):573-7. PubMed ID: 9433163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are treatments for vasovagal syncope effective? A meta-analysis.
    Vyas A; Swaminathan PD; Zimmerman MB; Olshansky B
    Int J Cardiol; 2013 Sep; 167(5):1906-11. PubMed ID: 22626839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of pathophysiology and therapy of patients with vasovagal syncope.
    White CM; Tsikouris JP
    Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of closed loop stimulation in patients with cardioinhibitory vasovagal syncope confirmed by head-up tilt table testing: a systematic review and meta-analysis.
    Ruzieh M; Ghahramani M; Nudy M; Naccarelli GV; Mandrola J; Grubb BP; Foy AJ
    J Interv Card Electrophysiol; 2019 Jun; 55(1):105-113. PubMed ID: 30863907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI.
    Sheldon RS; Lei L; Guzman JC; Kus T; Ayala-Paredes FA; Angihan J; Safdar S; Maxey C; Bennett G; Raj SR
    Europace; 2019 Nov; 21(11):1733-1741. PubMed ID: 31538180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.
    Romme JJ; Reitsma JB; Black CN; Colman N; Scholten RJ; Wieling W; Van Dijk N
    Cochrane Database Syst Rev; 2011 Oct; (10):CD004194. PubMed ID: 21975744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for fainting spells.
    Harv Heart Lett; 1999 Sep; 10(1):3. PubMed ID: 10445969
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.